Scholars Central

EditorialPublished 29 Nov 2023

Analysis of the Therapeutic Value of Kunxian Tablet in Medical Treatment and Its Adverse Consequences

Authors: John Sekh

Department of Medicine Resources, Chengdu University of Traditional Chinese Medicine, China

Clinical Pharmacology & Biopharmaceutics

Volume 12 · Issue 11 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Kunxian Tablet is a traditional Chinese herbal medicine with a long history of use in various therapeutic applications. This abstract provides an overview of a comprehensive analysis of the therapeutic value and potential adverse consequences associated with Kunxian Tablet in medical treatment. The study combines a review of existing literature, clinical trials, and empirical evidence to assess the benefits and risks associated with its usage. The study emphasizes the importance of proper dosage, patient selection, and healthcare provider supervision when considering the use of Kunxian Tablet in medical treatment. To mitigate adverse consequences, it is crucial to promote evidence-based medicine and adhere to good manufacturing practices in the production of herbal medicines. Kunxian Tablet presents a promising avenue for therapeutic applications in traditional Chinese medicine. However, its use should be approached with caution, considering potential adverse consequences and the need for further research and standardization in this field. An informed and evidence-based approach is essential to harness the full therapeutic potential of Kunxian Tablet while ensuring patient safety and well-being.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “John Sekh”